DIAGNOSTIC SIGNIFICANCE OF CHANGES IN THE SMALL INTESTINE IN RHEUMATOID ARTHRITIS
Keywords:
These changes include: Reduced microbial diversity and overrepresentation of pathogenic bacteriaAbstract
RA is systemically linked to functional and structural changes in the intestinal mucosa, particularly in the small and large intestines
References
1. Гульнева М.Ю. Микробиоценоз кишечника при ревматоидном артрите в пожилом возрасте // Клиническая геронтология. – 2011. – № 3–4. – С. 8–12.
2. Вязникова О.А. Синдром диспепсии и патология верхних отделов желудочно-кишечного тракта у больных ревматоидным артритом: автореф. дис. ... канд. мед. наук. –Нижний Новгород, 2008. – 28 с.
3. Клинические рекомендации: ревматология / под ред. Е.Л. Насонова. – М.: ГЭОТАР–Медиа, 2010. – 752 с.
4. Козлова И.В. Апудоциты и тучные клетки при хронических воспалительных заболеваниях толстой кишки: клинико-морфологические сопоставления // Терапевтический архив. – 2000. – Т. 72, № 2. – С. 32–35.
5. Adebayo D., Bjarnason I. Is non-steroidal anti-infl ammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? // Postgrad. Med. J. – 2006. – Vol. 82. – P. 186–91.
6. Aletaha D. Rheumatoid arthritis classifi cation criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative // Ann. Rheum. Dis. – 2010. – Vol. 69. – P. 1580–8.
7. Hernanz A. Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factoralphaproduction by peripheral whole blood мcells from rheumatoid arthritis and osteoarthritispatients // Regul. Pept. – 2003. – Vol. 15, № 1. – Р. 1924.
8. Lanas A. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice // Am. J. Gastroenterol. – 2009. – Vol. 104, № 7. – P. 1633–41. Immunopathol. – 2010. – Vol. 32, № 1. – Р. 43–53.
10. Paul G. Green Gastrin-releasing peptide, substance P and cytokines in rheumatoid arthritis // Arthritis Res. Ther. –2005. – Vol. 7, № 3. – Р. 111–113.
11. Sartor R.B. Role of the enteric microfl ora in the pathogenesis of intestinal infl ammation and arthritis // Aliment. Pharmacol. Ther. – 1997. – Vol. 11, Suppl. 3. – P. 17–22.
12. Turesson C. Incidence and predictors of severe extraarticular disease manifestations in an early rheumatoid arthritis inception cohort // Ann. Rheum. Dis. – 2007. – Vol. 66. –P. 1543–4.
13. Zanin-Zhorov A. Protein kinase C-θ mediates negative feedback on regulatory T cell function // Science. – 2010. – Vol. 328. – P. 372–376.
14. Zhang L. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis // J. Clin. Immunol. –2011. – Vol. 31, № 4. – Р. 606–14.
15. Langhorst J.В., Boone J., Lauche R. et al. Fecal lactoferrin, calprotectin, PMN-elastase, CRP, and white blood cell count as indicators for mucosal healing and clinical course of disease in patients with mild to moderate ulcerative colitis: post hoc analysis of a prospective clinical trial. Journal of Chron’s & colitis. 2016; 10(7): 786-794. doi: 10.1186/s12876-016-0462-z.
16. Baker E.N., Baker H.M. Molecular structure, binding properties and dynamics of lactoferrin. Cell Molecular Life and Science. 2005; 62: 2531-2539. doi: 10.1007 /s00018-005-5368-9.
17. Gartia-Montoya I.A., Cendon T.S., Arevalo-Gallegos S. et al. Lactoferrin a multiple bioactive protein: An overview. Biochemical Biophysycal Acta. 2012; 1820: 226-236. doi: 10.1016 / j.bbagen.2011.06.018.
18. Troost F.J., Steijns J., Saris W.H., Brummer R.J. Gastric digestion of bovine lactoferrin in vivo in adults. Journal of Nutrition. 2001; 131(В): 2101-2104. doi: 10.1093/jn / 131.8.2101.
